{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:48:12Z","timestamp":1741153692571,"version":"3.38.0"},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,3]]},"abstract":"<jats:title>Lay Summary<\/jats:title>\n               <jats:p>Despite being a rare adverse event, Guillain-Barr\u00e9 syndrome should be a differential diagnosis in patients taking tumor necrosis factor alpha (TNF-\u03b1) inhibitors who develop neurological events. Ustekinumab seems to be a safe option after TNF-\u03b1 inhibitors in these patients.<\/jats:p>","DOI":"10.1093\/ibd\/izae235","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T19:35:03Z","timestamp":1727552103000},"page":"887-888","source":"Crossref","is-referenced-by-count":0,"title":["Challenges in the Management of Acute Severe Ulcerative Colitis in a Patient With Guillain-Barr\u00e9 Syndrome Associated With Infliximab"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9108-5489","authenticated-orcid":false,"given":"T\u00e2nia","family":"Carvalho","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Unidade Local de Sa\u00fade de Braga , Braga ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Pinto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Unidade Local de Sa\u00fade de Braga , Braga ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5852-204X","authenticated-orcid":false,"given":"Jos\u00e9","family":"Ara\u00fajo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Unidade Local de Sa\u00fade de Braga , Braga ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3066-1371","authenticated-orcid":false,"given":"D\u00e1lia","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Unidade Local de Sa\u00fade de Braga , Braga ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5930-8611","authenticated-orcid":false,"given":"Raquel","family":"Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Unidade Local de Sa\u00fade de Braga , Braga ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5634-4870","authenticated-orcid":false,"given":"Bruno","family":"Arroja","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Unidade Local de Sa\u00fade de Braga , Braga ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"issue":"7","key":"2025030423102067000_CIT0001","doi-asserted-by":"publisher","first-page":"938","DOI":"10.2174\/1570159X14666161213114904","article-title":"Biological drugs in Guillain-Barr\u00e9 syndrome: an update","volume":"15","author":"Motamed-Gorji","year":"2017","journal-title":"Curr Neuropharmacol."},{"issue":"2","key":"2025030423102067000_CIT0002","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4081\/reumatismo.2019.1115","article-title":"Etanercept biosimilar associated with Guillain-Barr\u00e9 syndrome: insights from a case","volume":"71","author":"Shobha","year":"2019","journal-title":"Reumatismo"},{"key":"2025030423102067000_CIT0003","doi-asserted-by":"publisher","first-page":"bcr2017219481","DOI":"10.1136\/bcr-2017-219481","article-title":"Guillain-Barr\u00e9 syndrome in association with antitumour necrosis factor therapy: a case of mistaken identity","volume":"2017","author":"Patwala","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"12","key":"2025030423102067000_CIT0004","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1093\/ecco-jcc\/jjaa101","article-title":"Guillain-Barr\u00e9 syndrome in a Crohn`s disease patient treated with vedolizumab","volume":"14","author":"de Azevedo","year":"2020","journal-title":"J Crohns Colitis."},{"issue":"4","key":"2025030423102067000_CIT0005","doi-asserted-by":"publisher","first-page":"324","DOI":"10.11405\/nisshoshi.116.324","article-title":"[A case of Crohn\u2019s disease complicated by Guillain-Barr\u00e8 syndrome during ustekinumab therapy]","volume":"116","author":"Fukushima","year":"2019","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"issue":"5","key":"2025030423102067000_CIT0006","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s10067-017-3573-1","article-title":"Is secukinumab a safe alternative treatment for ankylosing spondylitis with Guillain Barr\u00e9 syndrome after anti-TNF-\u03b1 treatment? Case report and literature review","volume":"36","author":"Psarelis","year":"2017","journal-title":"Clin Rheumatol."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izae235\/59419547\/izae235.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/3\/887\/59419547\/izae235.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/3\/887\/59419547\/izae235.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T23:11:08Z","timestamp":1741129868000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/3\/887\/7789548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":6,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9,28]]},"published-print":{"date-parts":[[2025,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izae235","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"type":"print","value":"1078-0998"},{"type":"electronic","value":"1536-4844"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,9,28]]}}}